3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Ganglioneuroblastoma
1
Interventions
Mitomycin
12
Gemcitabine
9
BCG Vaccine
4
apaziquone
3
Epirubicin
3
erdafitinib
2
durvalumab
2
dodecyl maltoside
2
VB4-845
2
Docetaxel
2
viscum album peptide
1
valrubicin
1
pirarubicin
1
hydroxycamptothecinum
1
Transurethral Resection of Bladder
1
Therapeutic Uses
1
Standard of Care
1
Saline Solution
1
Radiotherapy
1
Polysorbates
1
Maintenance
1
Magnetic Resonance Spectroscopy
1
Injections
1
Cystoscopy
1
5-aminolevulinic acid hexyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Non-Muscle Invasive Bladder Neoplasms
×
Transurethral Resection of Bladder
×
Clear all
NCT07000084
2026-04-07
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
330 enrolled